Evidence for a New Pathophysiological Mechanism for Coronary Artery Disease Regression : Hepatic Lipase Mediated Changes in LDL Density

Circulation - United States
doi 10.1161/01.cir.99.15.1959
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Nanoparticle-Mediated Drug Delivery System for Coronary Artery Disease

Drug Delivery System
Pharmaceutical Science
2015English

Role of Hepatic Lipase and Endothelial Lipase in High-Density Lipoprotein—Mediated Reverse Cholesterol Transport

Current Atherosclerosis Reports
Cardiovascular MedicineCardiology
2011English

Oxidized LDL and Malondialdehyde-Modified LDL in Patients With Acute Coronary Syndromes and Stable Coronary Artery Disease

Circulation
Cardiovascular MedicinePhysiologyCardiology
1998English

Novel Regulators of Low-Density Lipoprotein Receptor and Circulating LDL-C for the Prevention and Treatment of Coronary Artery Disease

2012English

PCI or CABG for Unprotected Left Main Coronary Artery Disease?—new Evidence Justifies a Change in Perspective

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2018English

Investigation of MDA-LDL (Malondialdehyde-Modified Low-Density Lipoprotein) as a Prognostic Marker for Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus

Clinica Chimica Acta
MedicineBiochemistryClinical Biochemistry
2015English

Changes in Pericardial Fat Composition After Radiotherapy: Implications for Coronary Artery Disease?

Heart Lung and Circulation
Respiratory MedicinePulmonaryCardiovascular MedicineCardiology
2019English

Surgery for Coronary Artery Disease.

BMJ
1978English

Operations for Coronary Artery Disease

American Journal of Nursing
MedicineNursing
1954English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy